https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/accounts-and-notes-receivable-net https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/accounts-payable-trade-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/advertising-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/allowance-for-doubtful-accounts-premiums-and-other-receivables https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/assets-held-for-sale-at-carrying-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/assets-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/business-exit-costs https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cash-provided-by-used-in-financing-activities-discontinued-operations https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cash-reserve-deposit-required-and-made https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cash-uninsured-amount https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/clinical-trials https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/commitments-and-contingencies https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/convertible-debt https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cost-of-goods-sold-depreciation https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-convertible-number-of-equity-instruments https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-decrease-forgiveness https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-face-amount https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-periodic-payment https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-periodic-payment-principal https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-severance-payments https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/deposits https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/depreciation-nonproduction https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/derivative-gain-on-derivative https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/derivative-liabilities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/dilutive-shares https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/discontinued-operation-gain-loss-on-disposal-of-discontinued-operation-net-of-tax https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/discontinued-operation-income-loss-from-discontinued-operation-during-phase-out-period-net-of-tax https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/discontinued-operation-income-loss-from-discontinued-operation-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-accounts-notes-and-loans-receivable-net https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-accounts-payable https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-accrued-liabilities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-costs-of-goods-sold https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-gross-profit-loss https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-inventory https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-operating-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-operating-income-loss https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-other-noncurrent-assets https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-property-plant-and-equipment https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/disposal-group-including-discontinued-operation-revenue https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/due-to-employees-current-and-noncurrent https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/due-to-officers-or-stockholders-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/embedded-derivative-no-longer-bifurcated-amount-reclassified-to-stockholders-equity https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/escrow-deposit https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/escrow-deposit-disbursements-related-to-property-acquisition https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/escrow-deposits-related-to-property-sales https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/extinguishment-of-debt-gain-loss-net-of-tax https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/federal-deposit-insurance-corporation-premium-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-patents-gross https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/finite-lived-trademarks-gross https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/gross-profit https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/impairment-of-leasehold https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/income-loss-before-extraordinary-items-and-cumulative-effect-of-change-in-accounting-principle https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/income-loss-from https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/income-loss-from-operations-before-extraordinary-items-per-basic-and-diluted-share https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/increase-decrease-in-operating-assets https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/increase-decrease-in-operating-liabilities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/indefinite-lived-trademarks https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/insurance-settlements-receivable https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/insurance-settlements-receivable-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/inventory-gross https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/inventory-write-down https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/investment-warrants-exercise-price https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/litigation-reserve https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/litigation-settlement-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/net-cash-from https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/net-cash-from-discontinued-operations https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/notes-and-loans-receivable-net-noncurrent https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/other-asset-impairment-charges https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/other-assets https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/other-general-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/other-inventory-supplies https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/other-restructuring-costs https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/paid-in-kind-interest https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/prepaid-insurance https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-life-insurance-policies https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-repayments-of-long-term-debt-and-capital-securities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-sale-of-notes-receivable https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-sale-of-real-estate https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/property-plant-and-equipment-transfers-and-changes https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/repayments-of-long-term-debt-and-capital-securities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/restructuring-charges https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-10-k405 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-10ksb https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-10ksb40 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-10qsb https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-def-14c https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-defm14c https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-defs14a https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-prem14c https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-prer14a https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-prer14c https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/sec-filings-revoked https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-424b7 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-del-am https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/segment-reporting-information-net-assets https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/settlement-liabilities-current https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/severance-costs https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/severance-costs-1 https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/significant-purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/significant-supply-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-rsu-nonvested-intrinsic-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-award-rsu-vested-in-period-intrinsic-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-dividend https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-nonvested-options-forfeited-grant-date-fair-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stock-redeemed-or-called-value https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/stockholders-equity-other https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/supplemental-unemployment-benefits-salary-continuation https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/rock-creek-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted